½ÃÀ庸°í¼­
»óǰÄÚµå
1561543

³Ãµ¿¿ä¹ý ½ÃÀå º¸°í¼­ : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°(2024-2032³â)

Cryotherapy Market Report by Product, Application, End User, and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 137 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ³Ãµ¿¿ä¹ý ½ÃÀå ±Ô¸ð´Â 2023³â 3¾ï 2,990¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. IMARC GroupÀº ÇâÈÄ ½ÃÀåÀÌ 2032³â±îÁö 5¾ï 3,980¸¸ ´Þ·¯¿¡ À̸¦ Àü¸ÁÀ̸ç, 2024³âºÎÅÍ 2032³â±îÁö 5.5%ÀÇ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ³ëÀÎ Àα¸ Áõ°¡, ¾Ï À¯º´·ü Áõ°¡, ºÒ¾È, õ½Ä, ÆíµÎÅë, ±ÙÀ°Åë Áõ·Ê Áõ°¡°¡ ½ÃÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÀϺÎÀÔ´Ï´Ù.

³Ãµ¿¿ä¹ýÀº ±ØÀú¿ÂÀ» Ä¡·á¿¡ ÀÌ¿ëÇÏ´Â ÀÇ·á¿ä¹ýÀÔ´Ï´Ù. ½ÅüÀÇ ÅëÁõÀ» ÁÙÀ̰í Äݶó°Õ »ý¼ºÀ» ÃËÁøÇÏ¿© ÇǺΠ°Ç°­°ú Áú°¨À» Çâ»ó½Ãŵ´Ï´Ù. ¶ÇÇÑ Ã¼³»ÀÇ ¹éÇ÷±¸ ¼öÁØÀ» »ó½Â½ÃÄÑ ¸é¿ª ±â´ÉÀ» ³ôÀÌ´Â È¿°úµµ ÀÖ½À´Ï´Ù. ¶ÇÇÑ ³Ãµ¿¿ä¹ýÀº ¸Ó¸®ÀÇ Ç÷°üÀ» ¼öÃà½ÃÄÑ ¿°ÁõÀ» ¾ïÁ¦ÇÏ¿© ÆíµÎÅë°ú µÎÅëÀÇ ¿ÏÈ­¿¡µµ µµ¿òÀÌ µË´Ï´Ù. ½ºÆ÷Ã÷ ¿Ü»ó, °üÀý¿°, ÇǺΠÁúȯ, ¸¸¼º ÅëÁõ µî ´Ù¾çÇÑ º´¸®ÀÇ Ä¡·á¿¡ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ºÆ÷Ã÷ ¼±¼ö´Â ±ÙÀ° ÇÇ·Î¿Í °°Àº ½ºÆ÷Ã÷ ºÎ»óÀ» Ä¡·áÇÏ°í ºÎ»ó ÈÄ È¸º¹À» °¡¼ÓÈ­ÇÏ°í ¼º´ÉÀ» Çâ»ó½ÃŰ´Â µ¥¿¡µµ »ç¿ëµË´Ï´Ù.

³Ãµ¿¿ä¹ý ½ÃÀå µ¿Çâ :

ÇöÀç ½ºÆ÷Ã÷ ¹× ÇÇÆ®´Ï½º Ȱµ¿ÀÇ ÀαⰡ ³ô¾ÆÁü¿¡ µû¶ó ½ºÆ÷Ã÷ ºÎ»ó ¹ß»ý·üÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. À̰ÍÀº ¼¼°èÀÇ ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. °Ô´Ù°¡ °í·É Àα¸ Áõ°¡¿Í ¾ÏÀÇ À¯º´·ü Áõ°¡°¡ Á¶±â ȸº¹, ÇÕº´ÁõÀÇ °æ°¨, ÀÔ¿ø ±â°£ÀÇ ´ÜÃàÀ» ¸ñÀûÀ¸·Î ÇÑ ³Ãµ¿¿ä¹ý¿¡ ´ëÇÑ ¼ö¿ä¸¦ ȯ±âÇϰí ÀÖ½À´Ï´Ù. À̰ÍÀº ¾É¾ÆÀÖ´Â ¶óÀÌÇÁ ½ºÅ¸ÀÏ, °Ç°­¿¡ ÇØ·Î¿î ´ÙÀÌ¾îÆ® ÆÐÅÏ, ºÒ¾È, õ½Ä, ÆíµÎÅë, ±ÙÀ°ÅëÀÇ Áõ·Ê°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÁÁÀº ½ÃÀå Àü¸ÁÀ» âÃâÇÕ´Ï´Ù. À̿ʹ º°µµ·Î ¼Ò¼È ¹Ìµð¾îÀÇ ¿µÇâ·ÂÀÌ ³ô¾ÆÁö°í, À£ºùÀ̳ª ¹Ì¿ë Ä¡·á¿¡ ´ëÇÑ °ü½É Áõ°¡°¡ ÇǺΠÁúȯ¿¡ ´ëÇÑ ºñħ½ÀÀû Ä¡·á¿¡ ´ëÇÑ ÃëÇâ Áõ°¡¿Í ÇÔ²² ½ÃÀåÀÇ ¼ºÀåÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºñ¿ë È¿°úÀûÀÎ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¼ö¼ú°ú °°Àº °ªºñ½Ñ Ä¡·á¸¦ ´ëüÇÒ ¼ö ÀÖ´Â Ä¡·á¹ýÀ¸·Î¼­ ³Ãµ¿¿ä¹ý¿¡ ´ëÇÑ ¼ö¿ä°¡ Ã˹ߵǰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ¿°Áõ, ·ù¸¶Æ¼½º °üÀý¿°, ¸¸¼º ÅëÁõ Ä¡·á¸¦ À§ÇÑ Å©¶óÀÌ¿À è¹ö¿Í Å©¶óÀÌ¿À »ç¿ì³ªÀÇ °³¹ßÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ³Ãµ¿¿ä¹ýÀÇ ÀÌ¿ë ¿ëÀ̼º°ú °¡°Ý »ó½ÂÀÌ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á ÀÎÇÁ¶óÀÇ »ó´çÇÑ °³¼±°ú ¿¬±¸°³¹ß(R&D) Ȱµ¿¿¡ ´ëÇÑ ´ë±Ô¸ð ÅõÀÚ´Â ¼¼°è ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ±âŸ ¼¼°è ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎÀ¸·Î´Â °¡Ã³ºÐ ¼Òµæ Áõ°¡, ³Ãµ¿¿ä¹ýÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀÎÁöµµ Çâ»ó, À£´Ï½º ÇÇÆ®´Ï½º »ê¾÷ÀÇ À¶¼º µîÀÌ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

  • 2023³â ¼¼°èÀÇ ³Ãµ¿¿ä¹ý ½ÃÀå ±Ô¸ð´Â?
  • 2024³âºÎÅÍ 2032³â±îÁö ¼¼°è ³Ãµ¿¿ä¹ý ½ÃÀåÀÇ ¿¹»ó ¼ºÀå·üÀº?
  • ¼¼°èÀÇ ³Ãµ¿¿ä¹ý ½ÃÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎÀº?
  • ¼¼°èÀÇ ³Ãµ¿¿ä¹ý ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâÀº?
  • ¼¼°è ³Ãµ¿¿ä¹ý ½ÃÀåÀÇ Á¦Ç°º° ³»¿ªÀº?
  • ¼¼°è ³Ãµ¿¿ä¹ý ½ÃÀåÀÇ ¿ëµµº° ³»¿ªÀº?
  • ¼¼°è ³Ãµ¿¿ä¹ý ½ÃÀåÀÇ ÃÖÁ¾ »ç¿ëÀÚº° ³»¿ªÀº?
  • ¼¼°è ³Ãµ¿¿ä¹ý ½ÃÀåÀÇ ÁÖ¿ä Áö¿ªÀº?
  • ¼¼°è ³Ãµ¿¿ä¹ý ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§ ¹× Á¶»ç ¹æ¹ý

  • Á¶»çÀÇ ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­¹®

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ³Ãµ¿¿ä¹ý ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ³»¿ª : Á¦Ç°º°

  • µ¿°á ¼ö¼ú ÀåÄ¡
    • ½ÃÀå µ¿Çâ
    • ÁÖ¿ä ºÎ¹®
      • Á¶Á÷ Á¢ÃË ÇÁ·Îºê
      • Á¶Á÷ ½ºÇÁ·¹ÀÌ ÇÁ·Îºê
      • Ç¥ÇÇ ¹× ÇÇÇÏ µ¿°á Ä¡·á ÀåÄ¡
    • ½ÃÀå ¿¹Ãø
  • ±¹¼Ò µ¿°á Ä¡·á ÀåÄ¡
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • Å©¶óÀÌ¿À è¹ö ¹× Å©¶óÀÌ¿À »ç¿ì³ª
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦7Àå ½ÃÀå ³»¿ª : ¿ëµµº°

  • ¿Ü°ú ¼ö¼ú ¿ëµµ
    • ½ÃÀå µ¿Çâ
    • ÁÖ¿ä ºÎ¹®
      • Á¾¾çÇÐ
      • ½ÉÀ庴ÇÐ
      • ÇǺΰú
      • ±âŸ
    • ½ÃÀå ¿¹Ãø
  • ÅëÁõ °ü¸®
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ȸº¹, °Ç°­ ¹× ¹Ì¿ë
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦8Àå ½ÃÀå ³»¿ª : ÃÖÁ¾ »ç¿ëÀÚº°

  • º´¿ø ¹× Àü¹® Ŭ¸®´Ð
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ³Ãµ¿¿ä¹ý ¼¾ÅÍ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø
  • ½ºÆÄ ¹× ÇÇÆ®´Ï½º ¼¾ÅÍ
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ¿¹Ãø

Á¦9Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ³»¿ª : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦10Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • °æÀïµµ
  • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Boston Scientific Corporation
    • Brymill Cryogenic Systems
    • CooperSurgical Inc.
    • Cortex Technology
    • CryoConcepts LP
    • Erbe Elektromedizin GmbH
    • Kriosystem-Care Sp. z oo
    • Medtronic plc
    • METRUM CRYOFLEX Sp. z oo Sp. k.
    • Pacira BioSciences Inc.
    • US Cryotherapy
    • Zimmer MedizinSysteme GmbH
AJY 24.10.08

The global cryotherapy market size reached US$ 329.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 539.8 Million by 2032, exhibiting a growth rate (CAGR) of 5.5% during 2024-2032. The growing geriatric population, increasing prevalence of cancer and increasing cases of anxiety, asthma, migraine, and muscle soreness represent some of the key factors driving the market.

Cryotherapy refers to a medical therapy that relies on extremely low temperatures for treatment. It helps reduce pain in the body and improves skin health and texture by promoting collagen production. It also helps boost immune function by increasing levels of white blood cells in the body. Moreover, cryotherapy aids in relieving migraines and headaches by constricting blood vessels in the head and reducing inflammation. It is employed to treat a variety of medical conditions, including sports injuries, arthritis, skin conditions, and chronic pain. It is also used by athletes to treat sports injuries, such as muscle strains, help speed up recovery time after injury, and improve performance.

Cryotherapy Market Trends:

At present, the growing popularity of sports and fitness activities is resulting in the increasing incidence of sports injuries. This represents one of the key factors positively influencing the market across the globe. In addition, the growing geriatric population and increasing prevalence of cancer are catalyzing the demand for cryotherapy for fast recovering, reducing complications, and minimizing hospital stays. This, in confluence with sedentary lifestyles, unhealthy dietary patterns, and increasing cases of anxiety, asthma, migraine, and muscle soreness, is creating a favorable market outlook. Apart from this, the rising influence of social media and the growing interest in wellness and beauty treatments, in confluence with the increasing preference for non-invasive treatments for skin conditions, is strengthening the market growth. Moreover, the rising demand for cost-effective treatment options is catalyzing the demand for cryotherapy as a potential alternative to more expensive treatments, such as surgeries. In line with this, the development of cryo-chambers and cryo-saunas for the treatment of inflammation, rheumatoid arthritis, and chronic pain, are fueling the market growth. Additionally, the increasing accessibility and the rising affordability of cryotherapy are contributing to the market growth. Furthermore, significant improvements in the healthcare infrastructure, along with extensive investments in research and development (R&D) activities, are fueling the growth of the market worldwide., Some of the other factors stimulating the growth of the market across the globe include inflating disposable incomes, increasing awareness about the benefits of cryotherapy, and flourishing wellness and fitness industries.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cryotherapy market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end user.

Product Insights:

  • Cryosurgery Devices
    • Tissue Contact Probes
    • Tissue Spray Probes
    • Epidermal and Subcutaneous Cryoablation Devices
  • Localized Cryotherapy Devices
  • Cryochambers and Cryosaunas

The report has provided a detailed breakup and analysis of the cryotherapy market based on the product. This includes cryosurgery devices (tissue contact probes, tissue spray probes, epidermal and subcutaneous cryoablation devices), localized cryotherapy devices, and cryochambers and cryosaunas. According to the report, cryochambers and cryosaunas accounted for the largest market share.

Application Insights:

  • Surgical Applications
    • Oncology
    • Cardiology
    • Dermatology
    • Others
  • Pain Management
  • Recovery, Health and Beauty

A detailed breakup and analysis of the cryotherapy market based on the application has also been provided in the report. This includes surgical applications (oncology, cardiology, dermatology, and others), pain management, and recovery, health and beauty. According to the report, pain management accounted for the largest market share.

End User Insights:

  • Hospitals and Specialty Clinics
  • Cryotherapy Centres
  • Spas and Fitness Centres

A detailed breakup and analysis of the cryotherapy market based on the end user has also been provided in the report. This includes hospitals and specialty clinics, cryotherapy centres, spas and fitness centres. According to the report, cryotherapy centres accounted for the largest market share.

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for cryotherapy. Some of the factors driving the North America cryotherapy market included the high disposable incomes, increasing incidences of sports injuries, rising awareness about the benefits of cryotherapy on skin conditions, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global cryotherapy market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Boston Scientific Corporation, Brymill Cryogenic Systems, CooperSurgical Inc., Cortex Technology, CryoConcepts LP, Erbe Elektromedizin GmbH, Kriosystem-Care Sp. z o.o., Medtronic plc, METRUM CRYOFLEX Sp. z o.o. Sp. k., Pacira BioSciences Inc., US Cryotherapy, Zimmer MedizinSysteme GmbH, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

  • 1. What was the size of the global cryotherapy market in 2023?
  • 2. What is the expected growth rate of the global cryotherapy market during 2024-2032?
  • 3. What are the key factors driving the global cryotherapy market?
  • 4. What has been the impact of COVID-19 on the global cryotherapy market?
  • 5. What is the breakup of the global cryotherapy market based on the product?
  • 6. What is the breakup of the global cryotherapy market based on the application?
  • 7. What is the breakup of the global cryotherapy market based on the end user?
  • 8. What are the key regions in the global cryotherapy market?
  • 9. Who are the key players/companies in the global cryotherapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cryotherapy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Cryosurgery Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Tissue Contact Probes
      • 6.1.2.2 Tissue Spray Probes
      • 6.1.2.3 Epidermal and Subcutaneous Cryoablation Devices
    • 6.1.3 Market Forecast
  • 6.2 Localized Cryotherapy Devices
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cryochambers and Cryosaunas
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Surgical Applications
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Oncology
      • 7.1.2.2 Cardiology
      • 7.1.2.3 Dermatology
      • 7.1.2.4 Others
    • 7.1.3 Market Forecast
  • 7.2 Pain Management
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Recovery, Health and Beauty
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Specialty Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cryotherapy Centres
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Spas and Fitness Centres
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Boston Scientific Corporation
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Brymill Cryogenic Systems
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 CooperSurgical Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Cortex Technology
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 CryoConcepts LP
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Erbe Elektromedizin GmbH
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Kriosystem-Care Sp. z o.o.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 METRUM CRYOFLEX Sp. z o.o. Sp. k.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Pacira BioSciences Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 US Cryotherapy
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Zimmer MedizinSysteme GmbH
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦